Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Stretch Mark

AARP Thanks Vice President Biden, Administration, For Working To Improve Health Care For Older Americans
This afternoon, AARP CEO A. Barry Rand delivered the following remarks at the White House Middle Class Task Force Town Hall in Alexandria, Va., during a discussion with Vice President Biden, Health and Human Services Secretary Kathleen Sebelius, and White House Office of Health Reform Director Nancy-Ann DeParle, on how health care reform will lower costs, cut waste, and improve quality for seniors from across the country.
generic viagra online
Simple Training Program Useful In Preventing Ankle Sprains
A study published recently on bmj.com concludes that an easy training program, based on a sequence of balancing movements, can be useful in cutting the risk of recurrent ankle sprains by 35 percent. This could reflect in huge savings in medical and lost productivity costs.
News of the day
Bevacizumab (Avastin(R)) Added To Common Chemotherapies Significantly Increases Tumour Shrinkage In HER2-negative Breast Cancer
Data presented at the American Society of Clinical Oncology (ASCO) 2009 meeting, in Orlando, Florida, show that bevacizumab (Avastin®) plus commonly used chemotherapies increases the chance of the patient living without the disease worsening by up to 36% compared to chemotherapies alone, in women receiving first-line therapy for advanced HER2-negative breast cancer. The Phase III RIBBON-1 study combined bevacizumab with chemotherapies, including capecitabine (Xeloda®), taxanes and anthracyclines and measured progression-free survival (PFS).1 No new safety signals for bevacizumab were observed in the study.
Medical Devices

White House Reform Chief Was On Boards Of Health Companies With Suspect Practices

Before taking her job as the White House health reform director, Nancy-Ann DeParle earned more than $6 million serving on the boards of major health care corporations, some of which were accused of fraud, mismanagement and regulatory violations during her tenure, the Investigative Reporting Workshop at American University reports on MSNBC.com. Some critics say the corporate relationships could be a conflict of interest for DeParle. Also, while there"s no evidence DeParle was involved in or aware of allegedly fraudulent activities, in three cases, she served on board committees overseeing the companies" legal and regulatory compliance. For instance, while serving as a director, and compliance committee member at DaVita Inc., a chain of dialysis centers, the company was the "subject of several government probes into its billing and drug-prescribing practices." While DeParle served a similar role at Guidant, it was revealed that the medical equipment supplier knew of cases in which its devices failed, but didn"t disclose the information. "The investigations and lawsuits are at odds with DeParle"s reputation in Washington as a progressive, highly respected health policy analyst," the Investigative Workshop Reports. "During the late 1990s, when she ran Medicare, she pushed hard to raise medical quality standards and to clamp down on fraud and waste in the massive federal health plan for the elderly" (Schulte, 7/2). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009